XPO1 May Be Therapeutically Targetable in KRAS-Mutant NSCLC | Citedby Results | Cancer Discovery | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

XPO1 May Be Therapeutically Targetable in KRAS-Mutant NSCLC

Cancer Discov (2016) 6 (11): OF10.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling

Lin Rong
Ruixing Zhao
Jinxiu Lu

Biochemical and Biophysical Research Communications (2017) 484 (3): 586.